Ranibizumab for macular edema due to retinal vein occlusions: Long-term follow-up in the HORIZON trial

Ophthalmology

Volumn 119, Issue 4, 2012, Pages 802-809

  Heier, Jeffrey S ^a   Campochiaro, Peter A ^b   Yau, Linda ^c   Li, Zhengrong ^c   Saroj, Namrata ^c   Rubio, Roman G ^c   Lai, Phillip ^c  

^a OPHTHALMIC CONSULTANTS OF BOSTON   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RANIBIZUMAB; VASCULOTROPIN;

AGED; ARTICLE; CATARACT; CENTRAL RETINA VEIN OCCLUSION; CONJUNCTIVAL HEMORRHAGE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE SEVERITY; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; ENDOPHTHALMITIS; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; INCIDENCE; INTRAOCULAR PRESSURE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETINA FOVEA; RETINA MACULA EDEMA; RETINA VEIN OCCLUSION; RHINOPHARYNGITIS; SIDE EFFECT; THROMBOEMBOLISM; VISUAL ACUITY;

AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; INTRAVITREAL INJECTIONS; MACULAR EDEMA; MALE; RETINAL VEIN OCCLUSION; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 84862817252     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2011.12.005     Document Type: Article

References (16)

1. J.P. Ehlers, S. Fekrat Retinal vein occlusion: beyond the acute event Surv Ophthalmol 56 2011 281 299
2. R. Channa, M. Smith, P.A. Campochiaro Treatment of macular edema due to retinal vein occlusions Clin Ophthalmol 5 2011 705 713
3. P.A. Campochiaro, G. Hafiz, S.M. Shah Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator Mol Ther 16 2008 791 799 (Pubitemid 351426182)
4. H. Noma, H. Funatsu, S. Harino Vitreous inflammatory factors in macular edema with central retinal vein occlusion Jpn J Ophthalmol 55 2011 248 255
5. P.A. Campochiaro, J.S. Heier, L. Feiner BRAVO Investigators Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study Ophthalmology 117 2010 1102 1112
6. D.M. Brown, P.A. Campochiaro, R.P. Singh CRUISE Investigators Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study Ophthalmology 117 2010 1124 1133
7. D.M. Brown, P.A. Campochiaro, R.B. Bhisitkul Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study Ophthalmology 118 2011 1594 1602
8. P.A. Campochiaro, D.M. Brown, C.C. Awh Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study Ophthalmology 118 2011 2041 2049
9. P.J. Rosenfeld, D.M. Brown, J.S. Heier MARINA Study Group Ranibizumab for neovascular age-related macular degeneration N Engl J Med 355 2006 1419 1431 (Pubitemid 44511557)
10. D.M. Brown, P.K. Kaiser, M. Michels ANCHOR Study Group Ranibizumab versus verteporfin for neovascular age-related macular degeneration N Engl J Med 355 2006 1432 1444 (Pubitemid 44511558)
11. A.N. Antoszyk, L. Tuomi, C.Y. Chung, A. Singh FOCUS Study Group Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration (FOCUS): year 2 results Am J Ophthalmol 145 2008 862 874
12. Antiplatelet Trialists' Collaboration Collaborative overview of randomised trials of antiplatelet therapyI: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients BMJ 308 1994 81 106
13. Physician's Guide to Assessing and Counseling Older Drivers 2nd ed. 2010 American Medical Assoc. Chicago 69 140 http://www.ama-assn.org/resources/doc/ public-health/older-drivers-guide.pdf Accessed September 21, 2011
14. National Eye Institute National Plan for Eye and Vision Research Low vision and blindness rehabilitation 2011 US Department of Health and Human Services Bethesda http://www.nei.nih.gov/strategicplanning/np-low.asp Accessed June 2, 2011
15. A. Chan, J.S. Duker, T.H. Ko Normal macular thickness measurements in healthy eyes using Stratus optical coherence tomography Arch Ophthalmol 124 2006 193 198 (Pubitemid 43247068)
16. P.A. Campochiaro, D.F. Choy, D.V. Do Monitoring ocular drug therapy by analysis of aqueous samples Ophthalmology 116 2009 2158 2164